insights_auto
Mtazamo: Thamani itaongezeka kwa asilimia 74.1·Thamani itapungua kwa asilimia 0.0
Nenda kwenye kichupo cha uchanganuzichevron_right
REGN:NASDAQ
Regeneron Pharmaceuticals Inc
US$ 753.12
arrow_downward
-1.27%(-9.69) Siku 1
US$ 753.12
0.00% (0.00)
bedtimeBaada ya saa
Imefungwa: 13 Okt, 16:00:00 GMT -4 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya REGN...
Fungua
US$ 762.48
Juu
US$ 765.60
Chini
US$ 743.57
Mtaji wa soko
77.54B
Wastani wa kiasi cha mauzo
elfu 714.98
Kiasi cha mauzo ya hisa
elfu 629.52
Gawio
0.50%
Mgawo wa faida wa kila robo mwaka
US$ 0.94
Tarehe ya kutojumuisha gawio
18 Ago 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
18.62
Juu kwa wiki 52
US$ 859.34
Chini kwa wiki 52
US$ 553.86
EPS
US$ 40.45
Beta
0.16
Hisa za wawekezaji
101.14M
Idadi ya wafanyakazi
elfu 15
Fungua
US$ 762.48
Juu
US$ 765.60
Chini
US$ 743.57
Mtaji wa soko
77.54B
Wastani wa kiasi cha mauzo
elfu 714.98
Kiasi cha mauzo ya hisa
elfu 629.52
Gawio
0.50%
Mgawo wa faida wa kila robo mwaka
US$ 0.94
Tarehe ya kutojumuisha gawio
18 Ago 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
18.62
Juu kwa wiki 52
US$ 859.34
Chini kwa wiki 52
US$ 553.86
EPS
US$ 40.45
Beta
0.16
Hisa za wawekezaji
101.14M
Idadi ya wafanyakazi
elfu 15
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
News Corp
·
saa 1 iliyopita
Regeneron Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors
ad-hoc-news.de
·
saa 7 zilizopita
RBC raises target for Regeneron stock to USD 810.00
Zacks
·
saa 8 zilizopita
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
The Globe and Mail
·
saa 11 zilizopita
Citi Keeps Their Hold Rating on Regeneron (REGN)
Wasifu
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
Kuhusu Regeneron Pharmaceuticals Inc
Afisa Mkuu Mtendaji (CEO)Leonard Schleifer
Wafanyakazielfu 15.3
Lilianzishwa1988
Makao makuuTarrytown, New York, Marekani
Sekta-
Tovutiregeneron.com